Findings from Idorsia Pharmaceuticals Ltd. Has Provided New Data on CXC Chemokines (Quantification of Increased Biologically Active Cxcl12a Plasma Concentrations After Ackr3 Antagonist Treatment In Humans)
In: Clinical Trials Week, 2024-02-26, S. 96
Zeitungsartikel
Zugriff:
Titel: |
Findings from Idorsia Pharmaceuticals Ltd. Has Provided New Data on CXC Chemokines (Quantification of Increased Biologically Active Cxcl12a Plasma Concentrations After Ackr3 Antagonist Treatment In Humans)
|
---|---|
Zeitschrift: | Clinical Trials Week, 2024-02-26, S. 96 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
ISSN: | 1543-6772 (print) |
Sonstiges: |
|